WCG KMR Group Invites Biopharma Companies to Enroll in Cost Study

September 17, 2019

Applied Clinical Trials

The WIRB-Copernicus Group’s Clinical Services Division has announces that enrollment in WCG KMR Group’s 2019 Clinical Trial Cost Study is now open. In its fourth year, the study will produce benchmarks on trial cost and trial cost efficiency, enabling participants to realize cost savings.

For more information on the study and how to participate, click here. 

Related Content:

News